LPCN vs NDSN · rev $309.5K vs P/E 31, rev $817.7M
Lipocine Inc (LPCN) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
Latest reported NDSN revenue for 2026-07-31 was $817.7M. Net income was $152.8M. Revenue was down 42.0% from 2026-04-30 to 2026-07-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
LPCN currently screens at market cap $19.3M. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the LPCN and NDSN stock pages for the full models.
Not investment advice.